Below are the earnings highlights for ANI Pharmaceuticals, Inc. (ANIP):
Earnings: -$9.01 million in Q3 vs. -$4.45 million in the same period last year.
EPS: -$0.55 in Q3 vs. -$0.37 in the same period last year.
Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of $10.38 million or $0.64 per share for the period.
Analysts projected $0.55 per share
Revenue: $83.82 million in Q3 vs. $52.06 million in the same period last year.
-Guidance:
Full year EPS guidance: $1.34 - $1.62
Full year revenue guidance: $295 - $315 Mln
For comments and feedback contact: editorial@rttnews.com